PMV Pharmaceuticals, Inc. (PMVP) has a consensus analyst rating of Buy, based on 4 analysts covering the stock. Of those, 4 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for PMVP is $18.00, representing a +1,124.5% upside from the current price of $1.47. Price targets range from a low of $5.00 to a high of $36.00.
